The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis

Bryna S. M. Chow; Christine Koulis; Pooja Krishnaswamy; Ulrike M. Steckelings; Thomas Unger; Mark E. Cooper; Karin A. Jandeleit-Dahm; Terri J. Allen

doi:10.1007/s00125-016-3977-5

The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis

Bryna S. M. Chow, Christine Koulis, Pooja Krishnaswamy, Ulrike M. Steckelings, Thomas Unger, Mark E. Cooper, Karin A. Jandeleit-Dahm, Terri J. Allen

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1778-1790
Journal	Diabetologia
Volume	59
Issue number	8
DOIs	https://doi.org/10.1007/s00125-016-3977-5
Publication status	Published - Aug 2016

Keywords

Angiotensin II
AT(2) receptor
Atherosclerosis
Compound 21
Diabetes

Access to Document

10.1007/s00125-016-3977-5

Cite this

Chow, B. S. M., Koulis, C., Krishnaswamy, P., Steckelings, U. M., Unger, T., Cooper, M. E., Jandeleit-Dahm, K. A., & Allen, T. J. (2016). The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis. Diabetologia, 59(8), 1778-1790. https://doi.org/10.1007/s00125-016-3977-5

@article{eae070518450435fb014cbf01bec0835,

title = "The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis",

keywords = "Angiotensin II, AT(2) receptor, Atherosclerosis, Compound 21, Diabetes",

author = "Chow, {Bryna S. M.} and Christine Koulis and Pooja Krishnaswamy and Steckelings, {Ulrike M.} and Thomas Unger and Cooper, {Mark E.} and Jandeleit-Dahm, {Karin A.} and Allen, {Terri J.}",

year = "2016",

month = aug,

doi = "10.1007/s00125-016-3977-5",

language = "English",

volume = "59",

pages = "1778--1790",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer, Cham",

number = "8",

}

The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis. / Chow, Bryna S. M.; Koulis, Christine; Krishnaswamy, Pooja; Steckelings, Ulrike M.; Unger, Thomas; Cooper, Mark E.; Jandeleit-Dahm, Karin A.; Allen, Terri J.

In: Diabetologia, Vol. 59, No. 8, 08.2016, p. 1778-1790.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis

AU - Chow, Bryna S. M.

AU - Koulis, Christine

AU - Krishnaswamy, Pooja

AU - Steckelings, Ulrike M.

AU - Unger, Thomas

AU - Cooper, Mark E.

AU - Jandeleit-Dahm, Karin A.

AU - Allen, Terri J.

PY - 2016/8

Y1 - 2016/8

KW - Angiotensin II

KW - AT(2) receptor

KW - Atherosclerosis

KW - Compound 21

KW - Diabetes

U2 - 10.1007/s00125-016-3977-5

DO - 10.1007/s00125-016-3977-5

M3 - Article

VL - 59

SP - 1778

EP - 1790

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 8

ER -